Orchestra biomed holdings, inc.OBIO.US Overview
OBIO Overall Performance
OBIO AI Analysis & Strategy
OBIO Recent Performance
-0.90%
Orchestra biomed holdings, inc.
0.81%
Avg of Sector
-1.14%
S&P500
OBIO PowerScanner
OBIO Key Information
OBIO Valuation Metrics
OBIO Earnings Table
OBIO Profile
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.